- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00291824
Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
A Randomized Controlled Trial of the Effects and Expense of a Primary and Secondary Cardiovascular Risk Reduction Clinic in Primary Care
Study Overview
Status
Intervention / Treatment
Detailed Description
Background: Uncontrolled hypertension, hyperlipidemia, hyperglycemia, smoking and other cardiovascular risks remain at epidemic proportions despite known efficacious treatments. Issues of both provider and patient behavioral non-adherence to guidelines and therapeutic regimes, respectively, are key factors in non-control. Few interventions aimed at reducing cardiovascular risk factors are based on sound theories of behavior change.
Objective: To assess the effectiveness and expense of three approaches to the care of persons with known risks for cardiovascular disease. The three treatment approaches are usual care, usual care plus nurse telephone calls, and usual care plus clinic visits to a nurse and/or physician.
Design: Patients will be randomized to a 1) specialized proactive, and holistic cardiovascular risk management clinic using principles of behavior change; 2) nurse telephone calls as an attention placebo, yet a low dose, health promotion intervention; and 3) usual primary care. A random sample of 670 patients with cardiovascular risks identified in the past five years will be selected. Patients will be excluded if they do not speak English, are cognitively impaired or live in a nursing home. Interview questionnaires will measure cardiovascular risk, intention to change, social support, depression, coping and health services use. In addition, patients will be required to give a blood sample to measure cholesterol and glucose levels. Patients will then be randomized to one of three treatment groups.
Significance: The expected findings of this study is that the cardiovascular clinic, with nurse and physician, will be most effective at reducing cardiovascular risk and will pay for itself by averting hospital and emergency use for cardiovascular events.
Study Type
Enrollment
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Ontario
-
Burlington, Ontario, Canada, L7R4C7
- Recruiting
- Caroline Medical Group
-
Contact:
- Michael Mills, MD CCFP
-
Contact:
- Donna Landry
- Phone Number: 103 905.632.8007
-
Sub-Investigator:
- Lori Chalklin, MD CCFP
-
Sub-Investigator:
- David Wallik, MD CCFP
-
Sub-Investigator:
- James Kraemer, MD CCFP
-
Sub-Investigator:
- Stephen Duncan, MD CCFP
-
Sub-Investigator:
- Chris Williams, MD CCFP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A random sample of all persons with visits to their primary care physician for cardiovascular risks in past year. Cognitively intact (mini-mental state) or living with a carer who is cognitively intact. All other co-morbidities
Exclusion Criteria:
- Presently in a nursing home or in-patient long-term care facility (already receiving medications and diets as prescribed). No available family/friend interpreter if non-English speaking.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Current Interview or Chart
|
|
International classification of diseases
|
|
Characteristics/demographics (dob, gender, marital status, living arrangement, employment, culture, language, spiritual beliefs, concurrent diseases - number/type).
|
|
Cognition: 10 item short portable mental status questionnaire (SPMSQ)(Pfeiffer, 1975)
|
|
Number of MD visits for cardiovascular risk factor
|
|
Percentage change in cardiovascular risk scores over time.
|
|
Percentage of targeted weight and exercise goals achieved (blood pressure control, smoking cessation, weight control, cholesterol control, sugar control, exercise levels). (Grundy, et al, 1999)
|
|
Self efficacy scale (Lorig et al, 1996)
|
|
Social support - personal resource questionnaire 85 (Weinert & Brandt 1987).
|
|
Depression (MADRS)(Montgomery & Asberg 1979) (Montgomery et al 1985) (Browne, Steiner Roberts et al 2002).
|
|
Coping (Moos and Billings 1984)
|
|
Expenditures of health and social services (Browne et al 2001)
|
|
Calculate the number of Framingham points for each risk factor
|
|
Blood samples
|
|
Counselling
|
|
Education
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Motivational Interviewing
|
|
Behavior Change
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Mills, MD CCFP, Caroline Medical Group
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHCTF G03-02656
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.